All In MedTech

Device Trial Radar · NCT00420875

Clinical Evaluation of Placement of Radiofrequency-based Plasma Microdebridement in the Treatment Algorithm for Foot and Ankle Tendinosis and Plantar Fasciosis

"Clinical Evaluation of Placement of Radiofrequency-based Plasma Microdebridement in the Treatment Algorithm for Foot and Ankle Tendinosis and Plantar Fasciosis"

Last checked: Nov 20, 2026Latest source record: Aug 26, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Jun 2007

Primary completion

Not stated

Sponsor

Lead sponsor
ArthroCare CorporationAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 11, 2007

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To determine the magnitude of improvement for pain and function symptoms over a two year period after enrollment into the registry study in patients presenting with chronic heel pain and receiving standard of care treatment. Standard of care will include traditional conservative care measures, ESWT, radiofrequency-based plasma microdebridement, scalpel debridement and/or surgical release.

Conditions

  • Plantar Fasciosis, Achilles Tendinosis

Interventions

  • TOPAZ MicroDebriderDevice

    The TOPAZ MicroDebrider will be used for patients that fail conservative care. Under sterile conditions in the operating room, patients will be given intravenous sedation (drugs that make you sleepy and unaware of your surroundings) in a hand vein and local anesthetic (drugs to numb the area where the surgical procedure will be done). Depending on the technique used the study doctor may or may not make an incision (cut) about 1 inch long on the side of your foot to expose your tendon. If the study doctor chooses to use the percutaneous method, an incision will not be made. The study doctor will put the tip of the TOPAZ MicroDebrider device (which is about 1/16th of an inch long) into the tendon. A current of energy will be applied on and around the tendon. Steri strips will be placed on the skin to close the area treated.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ankle Hind Foot Scale (AHS)Time frame: 6 weeks, 3 months, 6 months, 12 months, 18 months, 24 months

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Foot Care Physicians

    Mesa, Arizona

  • Foot and Ankle Institute of Santa Monica

    Santa Monica, California

  • Foot and Ankle Clinic of Oakwood

    Oakwood, Georgia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.